Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DHG Pharma is Vietnam’s largest domestic pharmaceutical manufacturer with over 50 years of history. The company produces a wide portfolio of generic medicines across multiple therapeutic categories as well as health supplements and cosmetics. It has a nationwide distribution network in Vietnam with more than 30 branches covering all regions. In recent years it has expanded exports to Southeast Asia with new product forms such as effervescent tablets for pain relief and fever reduction. The company reported strong financial growth in 2024 with revenues exceeding VND 5 trillion (~$197 million USD). No clinical trial results are published since the business model centers around generics rather than novel therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DHG Pharma.